click below
click below
Normal Size Small Size show me how
pht 101 c2p3
chapter 2 part 3
| Question | Answer |
|---|---|
| agonist | drugs that bind to a particular receptor site and trigger the cell's response in a manner similar to the action of the body's own chemical messenger |
| antagonist | drugs that bind to a receptor site and block the action of the endogenous messenger or other drugs; used to reverse benzodiazepine or narcotic overdoses |
| lipid | a fatty molecule, an important constituent of cell membranes |
| solubility | a drug's ability to dissolve in body fluids |
| pharmacokinetics | the activity of a drug within the body over a period of time; includes absorption, distribution, metabolism, and elimination |
| absorption | the process whereby a drug enters the circulatory system |
| distribution | the process by which a drug moves from the blood into other body fluids and tissues and ultimately to its sites of action |
| metabolism | the process by which drugs are chemically converted to compounds and then excreted through metabolic pathways |
| metabolite | a substance into which a drug is chemically converted in the body |
| induction | the process whereby a drug increases the concentration of certain enzymes that affect the pharmacologic response to another drug |
| inhibition | the process whereby a drug blocks enzyme activity and impairs the metabolism of another drug |
| elimination | removal of a drug or its metabolites from the body by excretion |
| clearance | the rate at which a drug is eliminated from a specific volume of blood per unit of time |
| dose | the quantity of a drug administered at one time |
| ceiling effect | a point at which no clinical response occurs with increased dose |
| bioavailability | the degree to which a drug or other substance becomes available to the target tissue after administration |
| first-pass effect | the extent to which a drug is metabolized by the liver before reaching systemic circulation |
| therapeutic range | the optimum dose, providing the best chance for successful therapy; dosing below this range has little effect on the healing process while overdosing can lead to toxicity and death |
| duration of action | the length of time a drug gives the desired response or is at the therapeutic level |
| loading dose | amount of drug that will bring the blood concentration to a therapeutic level quickly |
| volume of distribution | mathematical relationship between the blood concentration attained & the amount of drug administered |
| maintenance dose | amount of drug given at regular intervals to keep blood concentration therapeutic |
| pharmacokinetic modeling | a method of describing the process of absorption, distribution, metabolism, and elimination of a drug within the body |
| Therapeutic Effect | action for which the drug is prescribed or the desired pharmacological action of a drug in the treatment of a particular disease state or symptom |
| Local Effect | confined to a specific part of the body or an action of a drug that is confined to a specific part of the body |
| Systemic Effect | generalized, all-inclusive effect on entire body |
| Indications | the diseases, symptoms, and conditions for which the drug is known to be of benefit |
| Contraindications | the diseases, symptoms, and conditions for which the drug will not be beneficial and may do harm |
| Side Effects are the secondary responses to a drug other than | the primary therapeutic effect for which the drug was intended such as allergic responses & drug dependence, addiction, abuse, and tolerance |